Request for Covid-19 Impact Assessment of this Report
The United States Artesunate Medicines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Artesunate Medicines market, reaching US$ million by the year 2028. As for the Europe Artesunate Medicines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Artesunate Medicines players cover Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, and Ajanta Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Artesunate Medicines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Monoaromatic Artesunate
Compound Artesunate
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artesunate Medicines Market Size 2017-2028
2.1.2 Artesunate Medicines Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Artesunate Medicines Segment by Type
2.2.1 Monoaromatic Artesunate
2.2.2 Compound Artesunate
2.3 Artesunate Medicines Market Size by Type
2.3.1 Artesunate Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Artesunate Medicines Market Size Market Share by Type (2017-2022)
2.4 Artesunate Medicines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Artesunate Medicines Market Size by Application
2.5.1 Artesunate Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Artesunate Medicines Market Size Market Share by Application (2017-2022)
3 Artesunate Medicines Market Size by Player
3.1 Artesunate Medicines Market Size Market Share by Players
3.1.1 Global Artesunate Medicines Revenue by Players (2020-2022)
3.1.2 Global Artesunate Medicines Revenue Market Share by Players (2020-2022)
3.2 Global Artesunate Medicines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artesunate Medicines by Regions
4.1 Artesunate Medicines Market Size by Regions (2017-2022)
4.2 Americas Artesunate Medicines Market Size Growth (2017-2022)
4.3 APAC Artesunate Medicines Market Size Growth (2017-2022)
4.4 Europe Artesunate Medicines Market Size Growth (2017-2022)
4.5 Middle East & Africa Artesunate Medicines Market Size Growth (2017-2022)
5 Americas
5.1 Americas Artesunate Medicines Market Size by Country (2017-2022)
5.2 Americas Artesunate Medicines Market Size by Type (2017-2022)
5.3 Americas Artesunate Medicines Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artesunate Medicines Market Size by Region (2017-2022)
6.2 APAC Artesunate Medicines Market Size by Type (2017-2022)
6.3 APAC Artesunate Medicines Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artesunate Medicines by Country (2017-2022)
7.2 Europe Artesunate Medicines Market Size by Type (2017-2022)
7.3 Europe Artesunate Medicines Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artesunate Medicines by Region (2017-2022)
8.2 Middle East & Africa Artesunate Medicines Market Size by Type (2017-2022)
8.3 Middle East & Africa Artesunate Medicines Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artesunate Medicines Market Forecast
10.1 Global Artesunate Medicines Forecast by Regions (2023-2028)
10.1.1 Global Artesunate Medicines Forecast by Regions (2023-2028)
10.1.2 Americas Artesunate Medicines Forecast
10.1.3 APAC Artesunate Medicines Forecast
10.1.4 Europe Artesunate Medicines Forecast
10.1.5 Middle East & Africa Artesunate Medicines Forecast
10.2 Americas Artesunate Medicines Forecast by Country (2023-2028)
10.2.1 United States Artesunate Medicines Market Forecast
10.2.2 Canada Artesunate Medicines Market Forecast
10.2.3 Mexico Artesunate Medicines Market Forecast
10.2.4 Brazil Artesunate Medicines Market Forecast
10.3 APAC Artesunate Medicines Forecast by Region (2023-2028)
10.3.1 China Artesunate Medicines Market Forecast
10.3.2 Japan Artesunate Medicines Market Forecast
10.3.3 Korea Artesunate Medicines Market Forecast
10.3.4 Southeast Asia Artesunate Medicines Market Forecast
10.3.5 India Artesunate Medicines Market Forecast
10.3.6 Australia Artesunate Medicines Market Forecast
10.4 Europe Artesunate Medicines Forecast by Country (2023-2028)
10.4.1 Germany Artesunate Medicines Market Forecast
10.4.2 France Artesunate Medicines Market Forecast
10.4.3 UK Artesunate Medicines Market Forecast
10.4.4 Italy Artesunate Medicines Market Forecast
10.4.5 Russia Artesunate Medicines Market Forecast
10.5 Middle East & Africa Artesunate Medicines Forecast by Region (2023-2028)
10.5.1 Egypt Artesunate Medicines Market Forecast
10.5.2 South Africa Artesunate Medicines Market Forecast
10.5.3 Israel Artesunate Medicines Market Forecast
10.5.4 Turkey Artesunate Medicines Market Forecast
10.5.5 GCC Countries Artesunate Medicines Market Forecast
10.6 Global Artesunate Medicines Forecast by Type (2023-2028)
10.7 Global Artesunate Medicines Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Fosun Pharma (Guilin)
11.1.1 Fosun Pharma (Guilin) Company Information
11.1.2 Fosun Pharma (Guilin) Artesunate Medicines Product Offered
11.1.3 Fosun Pharma (Guilin) Artesunate Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Fosun Pharma (Guilin) Main Business Overview
11.1.5 Fosun Pharma (Guilin) Latest Developments
11.2 Ipca Laboratories
11.2.1 Ipca Laboratories Company Information
11.2.2 Ipca Laboratories Artesunate Medicines Product Offered
11.2.3 Ipca Laboratories Artesunate Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Ipca Laboratories Main Business Overview
11.2.5 Ipca Laboratories Latest Developments
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Information
11.3.2 Sanofi Aventis Artesunate Medicines Product Offered
11.3.3 Sanofi Aventis Artesunate Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Sanofi Aventis Main Business Overview
11.3.5 Sanofi Aventis Latest Developments
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Information
11.4.2 Ajanta Pharma Artesunate Medicines Product Offered
11.4.3 Ajanta Pharma Artesunate Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Ajanta Pharma Main Business Overview
11.4.5 Ajanta Pharma Latest Developments
11.5 Shin Poong
11.5.1 Shin Poong Company Information
11.5.2 Shin Poong Artesunate Medicines Product Offered
11.5.3 Shin Poong Artesunate Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Shin Poong Main Business Overview
11.5.5 Shin Poong Latest Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla Artesunate Medicines Product Offered
11.6.3 Cipla Artesunate Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Cipla Main Business Overview
11.6.5 Cipla Latest Developments
11.7 Acino
11.7.1 Acino Company Information
11.7.2 Acino Artesunate Medicines Product Offered
11.7.3 Acino Artesunate Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Acino Main Business Overview
11.7.5 Acino Latest Developments
11.8 MCW Healthcare
11.8.1 MCW Healthcare Company Information
11.8.2 MCW Healthcare Artesunate Medicines Product Offered
11.8.3 MCW Healthcare Artesunate Medicines Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 MCW Healthcare Main Business Overview
11.8.5 MCW Healthcare Latest Developments
12 Research Findings and Conclusion
Table 1. Artesunate Medicines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Monoaromatic Artesunate
Table 3. Major Players of Compound Artesunate
Table 4. Artesunate Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Artesunate Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Artesunate Medicines Market Size Market Share by Type (2017-2022)
Table 7. Artesunate Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Artesunate Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Artesunate Medicines Market Size Market Share by Application (2017-2022)
Table 10. Global Artesunate Medicines Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Artesunate Medicines Revenue Market Share by Player (2020-2022)
Table 12. Artesunate Medicines Key Players Head office and Products Offered
Table 13. Artesunate Medicines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Artesunate Medicines Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Artesunate Medicines Market Size Market Share by Regions (2017-2022)
Table 18. Americas Artesunate Medicines Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Artesunate Medicines Market Size Market Share by Country (2017-2022)
Table 20. Americas Artesunate Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Artesunate Medicines Market Size Market Share by Type (2017-2022)
Table 22. Americas Artesunate Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Artesunate Medicines Market Size Market Share by Application (2017-2022)
Table 24. APAC Artesunate Medicines Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Artesunate Medicines Market Size Market Share by Region (2017-2022)
Table 26. APAC Artesunate Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Artesunate Medicines Market Size Market Share by Type (2017-2022)
Table 28. APAC Artesunate Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Artesunate Medicines Market Size Market Share by Application (2017-2022)
Table 30. Europe Artesunate Medicines Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Artesunate Medicines Market Size Market Share by Country (2017-2022)
Table 32. Europe Artesunate Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Artesunate Medicines Market Size Market Share by Type (2017-2022)
Table 34. Europe Artesunate Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Artesunate Medicines Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Artesunate Medicines Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Artesunate Medicines Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Artesunate Medicines Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Artesunate Medicines Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Artesunate Medicines Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Artesunate Medicines Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Artesunate Medicines
Table 43. Key Market Challenges & Risks of Artesunate Medicines
Table 44. Key Industry Trends of Artesunate Medicines
Table 45. Global Artesunate Medicines Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Artesunate Medicines Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Artesunate Medicines Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Artesunate Medicines Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Artesunate Medicines Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Artesunate Medicines Market Size Market Share Forecast by Application (2023-2028)
Table 51. Fosun Pharma (Guilin) Details, Company Type, Artesunate Medicines Area Served and Its Competitors
Table 52. Fosun Pharma (Guilin) Artesunate Medicines Product Offered
Table 53. Fosun Pharma (Guilin) Artesunate Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Fosun Pharma (Guilin) Main Business
Table 55. Fosun Pharma (Guilin) Latest Developments
Table 56. Ipca Laboratories Details, Company Type, Artesunate Medicines Area Served and Its Competitors
Table 57. Ipca Laboratories Artesunate Medicines Product Offered
Table 58. Ipca Laboratories Main Business
Table 59. Ipca Laboratories Artesunate Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Ipca Laboratories Latest Developments
Table 61. Sanofi Aventis Details, Company Type, Artesunate Medicines Area Served and Its Competitors
Table 62. Sanofi Aventis Artesunate Medicines Product Offered
Table 63. Sanofi Aventis Main Business
Table 64. Sanofi Aventis Artesunate Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Sanofi Aventis Latest Developments
Table 66. Ajanta Pharma Details, Company Type, Artesunate Medicines Area Served and Its Competitors
Table 67. Ajanta Pharma Artesunate Medicines Product Offered
Table 68. Ajanta Pharma Main Business
Table 69. Ajanta Pharma Artesunate Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Ajanta Pharma Latest Developments
Table 71. Shin Poong Details, Company Type, Artesunate Medicines Area Served and Its Competitors
Table 72. Shin Poong Artesunate Medicines Product Offered
Table 73. Shin Poong Main Business
Table 74. Shin Poong Artesunate Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Shin Poong Latest Developments
Table 76. Cipla Details, Company Type, Artesunate Medicines Area Served and Its Competitors
Table 77. Cipla Artesunate Medicines Product Offered
Table 78. Cipla Main Business
Table 79. Cipla Artesunate Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Cipla Latest Developments
Table 81. Acino Details, Company Type, Artesunate Medicines Area Served and Its Competitors
Table 82. Acino Artesunate Medicines Product Offered
Table 83. Acino Main Business
Table 84. Acino Artesunate Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Acino Latest Developments
Table 86. MCW Healthcare Details, Company Type, Artesunate Medicines Area Served and Its Competitors
Table 87. MCW Healthcare Artesunate Medicines Product Offered
Table 88. MCW Healthcare Main Business
Table 89. MCW Healthcare Artesunate Medicines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. MCW Healthcare Latest Developments
List of Figures
Figure 1. Artesunate Medicines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artesunate Medicines Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Artesunate Medicines Market Size Market Share by Type in 2021
Figure 7. Artesunate Medicines in Hospital
Figure 8. Global Artesunate Medicines Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Artesunate Medicines in Clinic
Figure 10. Global Artesunate Medicines Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Artesunate Medicines in Other
Figure 12. Global Artesunate Medicines Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Artesunate Medicines Market Size Market Share by Application in 2021
Figure 14. Global Artesunate Medicines Revenue Market Share by Player in 2021
Figure 15. Global Artesunate Medicines Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Artesunate Medicines Market Size 2017-2022 ($ Millions)
Figure 17. APAC Artesunate Medicines Market Size 2017-2022 ($ Millions)
Figure 18. Europe Artesunate Medicines Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Artesunate Medicines Market Size 2017-2022 ($ Millions)
Figure 20. Americas Artesunate Medicines Value Market Share by Country in 2021
Figure 21. Americas Artesunate Medicines Consumption Market Share by Type in 2021
Figure 22. Americas Artesunate Medicines Market Size Market Share by Application in 2021
Figure 23. United States Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Artesunate Medicines Market Size Market Share by Region in 2021
Figure 28. APAC Artesunate Medicines Market Size Market Share by Application in 2021
Figure 29. China Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Artesunate Medicines Market Size Market Share by Country in 2021
Figure 36. Europe Artesunate Medicines Market Size Market Share by Type in 2021
Figure 37. Europe Artesunate Medicines Market Size Market Share by Application in 2021
Figure 38. Germany Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Artesunate Medicines Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Artesunate Medicines Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Artesunate Medicines Market Size Market Share by Application in 2021
Figure 46. Egypt Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Artesunate Medicines Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 52. APAC Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 53. Europe Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 55. United States Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 56. Canada Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 59. China Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 60. Japan Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 61. Korea Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 63. India Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 64. Australia Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 65. Germany Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 66. France Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 67. UK Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 68. Italy Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 69. Russia Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 70. Spain Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 73. Israel Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Artesunate Medicines Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Artesunate Medicines Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...